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The communal nature of living and training environments, alongside suboptimal hygiene and stressors in the field,
place military personnel at higher risk of contracting emerging infectious diseases. Some of these diseases spread
quickly within ranks resulting in large outbreaks, and personnel deployed are also often immunologically naïve to
otherwise uncommonly-encountered pathogens. Furthermore, the chance of weaponised biological agents being
used in conventional warfare or otherwise remains a very real, albeit often veiled, threat. However, such challenges
also provide opportunities for the advancement of preventive and therapeutic military medicine, some of which
have been later adopted in civilian settings. Some of these include improved surveillance, new vaccines and drugs,
better public health interventions and inter-agency co-operations. The legacy of successes in dealing with infectious
diseases is a reminder of the importance in sustaining efforts aimed at ensuring a safer environment for both
military and the community at large.
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Emerging and re-emerging infectious diseases are threats
that military organisations have to guard against, as they
cause substantial impact to operations and training. These
diseases may arise from within the military community, as
spill-over from the surrounding civilian populace, or
during military operations and deployments. Biological
warfare and bioterrorism are additional possibilities that
militaries need to be prepared for.
Since historical times, emerging infectious diseases have
impacted militaries, from the Plague of Athens in 430 BC
during the Peloponnesian War linked to the poisoning
of water reservoirs by the Spartans [1], and the similar
Antonine Plague in 166 AD brought back by returning
Roman soldiers from the Parthian War [2,3]. The Thirty
Years War from 1618 to 1648 also saw the devastating
effects of Typhus (alongside Plague and accompanying
starvation) which resulted in 10 million deaths [4], over-
shadowing 350,000 combat deaths. The weaponisation
of naturally occurring diseases, the threat wrought by
travelling soldiers returning home with novel diseases,
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unless otherwise stated.injuries (DNBIs) are still relevant to militaries of today. In
more recent times, there have been outbreaks reported
among military personnel in both peacetime and field
deployments. These include a peacetime Salmonella
outbreak in a military establishment in India in 2011
due to possible contamination of food [5], the 2013
scabies outbreak among the Queen’s Guards in the
United Kingdom after a military exercise in Germany
[6], and travellers’ diarrhoea among U.S. military troops
deployed during a training and humanitarian mission in El
Salvador in 2011 [7].
Deployment of militaries to foreign grounds also ex-
poses troops to local endemic diseases. A classic example
of this is malaria. During World War II and the Vietnam
War, 124,109 and 24,606 respective cases among U.S.
military personnel deployed to the Southwest Pacific and
Vietnam were reported [8,9]. Such infectious diseases have
been shown to impact militaries significantly, not only in
mortality and morbidity, but also in operational readiness.
Even training during peacetime is affected by disease out-
breaks, sometimes resulting in the unexpected suspension
of military operations [10].
Unlike civilian settings, the military may acquire emer-
ging and re-emerging infectious diseases from a myriad
of origins and these often spread more readily, posingThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Ho et al. Military Medical Research 2014, 1:21 Page 2 of 10
http://www.mmrjournal.org/content/1/1/21unique challenges to their prevention and control. At
the same time, the frequency and extent of outbreaks in
military settings provide opportunities to understand
these diseases, and to develop new strategies (Figure 1).
This review discusses some of the challenges militaries
face from infectious diseases, as well as the societal benefits
that militaries have brought to the world as these diseases
are managed.
Challenges in the military environment
Ease of disease transmission within military settings
Many diseases, especially airborne, food and water borne,
as well as vector borne diseases have been shown to
spread readily in the military due to the close communal
living and training quarters, operational constraints, and
unique field hygiene conditions. Harsh environments,
physical exertion and sleep deprivation, inadequate hy-
giene and sanitation, and psychological stress all result in
physiological and immunological changes [11]. Although
militaries comprise mostly young adults who are physic-
ally and mentally fitter, the above factors place them at
unusually higher risks of infection.
As a result, there have been numerous reports of in-
fectious disease outbreaks in military settings. These in-
clude, but are not limited to, gastroenteritis (particularly
Norwalk-like/norovirus outbreaks) [12-14], acute re-
spiratory infections (including influenza) [15-17] and
conjunctivitis (particularly due to adenovirus) [18-20].
One report documented that US military trainees staying
in a 60 person barracks were more susceptible to con-
tracting acute respiratory infections than those in 8 per-
son rooms, and that the risk was higher during the first
few weeks of training before declining to baseline [21].
Similarly, ease of transmission due to close living quar-
ters resulted in an Influenza A(H1N1) pdm09 outbreakCHALLENGES
Figure 1 Challenges and opportunities of emerging and re-emergingin a Swiss military boot camp in 2010 involving 105 of
750 recruits [16]. These incidences reflect the need for
preventive measures to protect against future incidences.
Transmission between military and the community
Some outbreaks in military settings are linked to an
increased incidence of disease in the local civilian popu-
lation. Although the extent of interactions between mili-
tary and civilian elements vary across militaries, some
mixing is inevitable either during transit of personnel
from one setting to another, or through socio-civic du-
ties such as disaster relief or community programs.
Amongst the many examples, a Hepatitis A outbreak
from 1976 to 1977 in a U.S. military was linked to a
nearby childcare facility [22], and concurrent civilian
and military outbreaks of Human Adenovirus type 14
in Texas and Oregon in 2007 had possible civilian epi-
demiological links [23]. There were also reports of
concurrent outbreaks of disease in both community
and military settings during the outbreaks of enterovi-
ral conjunctivitis in Singapore in 2005 [24] and mumps
in Luxembourg in 2008 [25]. Significantly, both of these
outbreaks occurred in small countries with military camps
in close proximity to the population where increased op-
portunities for mixing occur.
Infection during deployments
Military deployments are commonplace in this age of
globalisation and international co-operation, and this
coincides with the fact that infectious diseases cross
borders more frequently than ever before. Field and rural
deployments place personnel at risk of new pathogens not
normally encountered. As early as the First World War,
the return of military forces from deployments to the
trenches of Europe was suspected to have played a role inOPPORTUNITIES
infectious diseases in the military.
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More recently, 11 gastroenteritis outbreaks (10 caused by
viruses) among British troops deployed overseas from
2002 to 2007 were documented [27]. Personnel returning
to Australia from East Timor were also later diagnosed as
having been infected with dengue from 1999 to 2000 [28],
as did US servicemen infected with the malaria parasite in
Iraq, Afghanistan and Korea from 2003 to 2005 [29].
Table 1 shows a selection of infectious diseases during
more recent major military deployments and measures
implemented (See also Figure 2). Many of these were
ground breaking for their time, and provided evidence for
their routine use today.
The French Armed Forces reported that from 1999
to 2009, the rate of food borne disease outbreaks was
significantly higher in servicemen deployed overseas
(2.4 outbreaks/100,000 in France vs. 26.7 outbreaks/
100,000 overseas). These were attributed to a lack of
hygiene in operations and the consumption of unsafe
local food [62]. Likewise, more than one-half of the 865
infectious diarrhoeal outbreaks in the Israeli military from
1988 to 2002 were in field units [63]. Diseases also tend to
spread more efficiently during deployments, as seen by
the development of four outbreaks of Norwalk-like viruses
on board US Navy aircraft carriers from 1992 to 1997
which were attributed to crowding [50].
Military personnel are often also involved in disaster
management, where they interact with displaced popula-
tions, themselves at risk of infectious diseases [64]. Water
storage or stagnant water around temporary dwellings
promotes breeding of vectors, made worse by the absence
or interruption of vector control programmes. Further-
more, local food and water safety is poorly enforced, as
is the spread of respiratory pathogens when military
personnel interact with the local population. Vaccinations,
chemoprophylaxis and personal hygiene measures are
therefore critical in ensuring force protection when mili-
taries deploy to these areas.
Increasing deployment of military forces from developing
countries
Even developing country militaries that may not possess
sophisticated public health capabilities are able to utilise
many of the low cost disease prevention measures afore-
mentioned. Some of these forces also double-up as health
services for civilians in remote areas, reporting surveil-
lance data to local health authorities, and contributing to
national infectious disease surveillance [26]. Militaries also
provide surge capacity during natural or man-made disas-
ters when civilian resources are overwhelmed. There has
also been an increase in number of developing countries
contributing troops for multinational operations [26], and
common standards of disease control should be applied
to multilateral forces for collective protection. This mayentail the distribution of resources from higher-income
countries.
Novel infectious agents
Novel infectious agents such as zoonotic transmission of
avian influenza viruses and Middle East respiratory
syndrome coronavirus (MERS-CoV) pose challenges in
early detection and prevention strategies, including
military personnel who reside in or are deployed to
affected areas. Returning travellers from affected areas
also pose a threat and are difficult to screen if they visit
these areas during personal leave. The impact of novel
agents is shown by the effect of the 2009 pandemic
H1N1 influenza on militaries from overseas importation
or through the surrounding general population, with sub-
sequent rapid spread in the closed living environments
[65]. In addition, Dual Use Research of Concern (DURC)
raises issues with regards to biosafety and biosecurity,
such as that which involves the creation of laboratory-
modified H5N1 viruses capable of respiratory trans-
mission [66].
Biological warfare and bioterrorism
Biological agents have been used as weapons of war as
early as 600 B.C., when cadavers and animal carcasses
were used to weaken the enemy [67]. Blankets from small-
pox patients were distributed by the British to Native
Americans in 1763, and experiments involving various
pathogens (including anthrax and meningococcus) were
conducted by the Japanese biological warfare research
program during World War II, the latter leading to nu-
merous deaths [68]. Furthermore, biological agents can be
utilised through unconventional means. The intentional
contamination of salad bars in Oregon with Salmonella
Typhimurium by the Rajneeshee cult in 1984 [69], the
failed attempts to disperse botulinum toxin by the Japanese
cult Aum Shinrikyo at various sites in Japan in the 1990s
[70], and release of anthrax through mailed letters and
packages in the U.S. in 2001 [71] are constant reminders of
the ever present yet often concealed threat.
The need to protect against bioterrorism has thus
emerged as a priority for most militaries. As bioterrorism
can occur from the use of simple naturally occurring dis-
eases to the development or theft of dangerous pathogens,
it is important for militaries to prepare for and protect
themselves against these threats. This includes the devel-
opment of good diagnostic facilities for routine infectious
diseases detection that also have the capability for detec-
tion of novel and dangerous pathogens. Laboratories (both
military and civilian) should thus ensure the veracity of
biosafety and biosecurity practices to prevent the occur-
rence of accidents or deliberate releases. This requires col-
laborations at the international level to strengthen global
biosafety and biosecurity initiatives, and investments in
Table 1 Infectious diseases during military deployments and measures implemented
Operation Year Infectious diseases Measures implemented
American Civil War 1861 to 1865 Malaria [30] Use of Quinine
World War I 1914 to 1918 1918 Influenza [31] Improvements in respiratory hygiene
and isolation
Trench Foot [32] Footwear modifications
Foot protection (grease, borated talc
and camphor)
Measures to improve trench and boot
drainage
Tetanus [33] Prophylactic Anti-Tetanus serum to
wounded
World War II 1939 to 1945 Wound infections [34,35] Use of Dakin’s solution for antisepsis
Use of Sulfanilamide and Penicillin
Scrub Typhus [36] Development of delousing strategies
Malaria [37] Use of Atabrine
Lymphatic Filariasis [38]
Korean War 1950 to 1953 “Korean Haemorrhagic Fever”
(Hanta virus) [39]
Improvement in environmental health
measures
Vietnam War 1953 to 1975 Malaria and Dengue [40] Mosquito nets and repellents, Antimalarials
including Mefloquine - designed by army
to counter Chloroquine resistance.
Bubonic Plague (Yersinia pestis) [41] Flea insecticide and repellents
Immunisation with plague vaccines
Protective clothing and Rat proofed
dwellings
Persian Gulf War 1990 to 1991 Preparedness against Biological
Warfare [42]
Anthrax, Botulinum, Meningococcus
vaccines and Hepatitis A immunoglobulins
Operation Restore Hope 1993 Malaria [43] Use of Mefloquine and Doxycycline
Operation Enduring 2001 to 2011 Leishmaniasis [44] Genus specific probe for diagnosis
Freedom, Operation Iraqi
Freedom, Operation New
Treatment modalities under investigational
new drug protocols
Dawn Better shelters and insect repellents
Malaria [45] Use of rapid diagnostic assays and
Tafenoquine
Norovirus and Shigella [46-48] Use of rapid diagnostic assays





Improvements in infection control
practices, antibiotic restriction policies
Admission surveillance cultures of
wounded soldiers and contact isolation
Need for new antibiotics targeting
resistant Gram negative bacteria
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lower-resources.
Opportunities for militaries
Amidst these challenges, there are also multiple opportun-
ities afforded for advancements in the prevention and
control against infectious diseases in military settings, and
history has shown how military medicine has risen to pre-
vious challenges.Surveillance programs
Cross border spread and the emergence of novel pathogens
have placed surveillance programs, such as that of the
French Military Influenza Surveillance System (MISS) and
the U.S. Armed Forces Health Surveillance Centre Global
Emerging Infectious Surveillance and Response System
(AFHSC-GEIS), as centrepieces in the early detection and
warning of infectious diseases for the prompt implementa-
tion of mitigation and control measures.
Figure 2 Selected infectious diseases during military deployments [1-4,7-9,15,26,28-30,39,41,44,50-61].
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surveillance of infectious diseases. Through the US Naval
Health Research Centre’s surveillance program, Influenza
A(H1N1)pdm09 in two California children was first
identified, leading to the promulgation of an alert by
the Centers for Disease Control and Prevention (CDC)
[72]. This subsequently led to notification of another
outbreak among New York students who had travelled
to Mexico, and thereafter the detection of the same
pathogen in outbreaks in Mexico [72]. These represented
sentinel events leading to global awareness of the rapidly
evolving situation.
Influenza surveillance can also be found in other armed
forces, including the French who have participated in
national surveillance through MISS since 1997. Its main
objectives are the early detection of influenza outbreaks
and monitoring of circulating viral strains [73]. Com-
pared with national estimates, the MISS estimated lower
amplitudes of influenza outbreaks in the military from
2008 to 2012, with possible reasons including younger
ages, healthier personnel and compulsory influenza vac-
cination. In the Italian military, diseases such as measles
and varicella are notifiable under its surveillance program[74]. These results have been used to guide organisational
vaccination policies. For example, after a tenfold in-
crease in measles and fourfold increase in rubella from
1976–1980 to 1991–1995, mandatory MMR vaccination
was instituted. Likewise, on noting that influenza was
the foremost cause for febrile respiratory illnesses lead-
ing to substantial morbidity [75], the Singapore Armed
Forces thereafter instituted annual influenza vaccination
with significant success [76].
Military surveillance is often a component of wider
population-wide protection measures, such as the Medical
Surveillance System implemented in support of the United
Nations Mission in Haiti [77]. The Peruvian Navy also
developed an electronic disease surveillance to rapidly
consolidate reportable diseases, thereby allowing earlier
detection and control of disease outbreaks in the country.
Finally, the Royal Thai Army instituted HIV screening on
conscription, thereby serving as an indirect monitor of the
national HIV situation [26,78].
Public health interventions
Public health interventions are equally as important in
the management of infectious diseases in the military.
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of common living surfaces and hand hygiene, and droplet
and airborne protection including isolating ill individuals
and basic respiratory hygiene education. Food and water
hygiene is also important due to the large numbers of indi-
viduals sharing common food and water sources. Some of
these are more easily enforced in the controlled environ-
ments of military bases. However, once in the field, they
pose a unique challenge where inadequate hygiene and
sanitisation are often lacking. Even so, through innovations
such as ready-to-eat meals and a host of water purification
methods, militaries attempt to reduce these risks.
Positive examples of successful public health measures
include the early identification and isolation of patients
during the 1918 influenza pandemic which lowered at-
tack rates in closed settings [79], and enhanced public
health measures put in place for critical operations units
in the Singapore military during the Influenza A(H1N1)
pdm09 pandemic (including symptom monitoring and
segregation into smaller subgroups when working)
resulting in lower seroconversion rates (17% vs. 44% for
other units) [80]. Likewise, a study involving conjunctiv-
itis outbreaks in a military camp showed that for each
day to which control measures were delayed, the out-
break itself was extended by 0.82 days [81].
Health education also plays an important role amongst
military personnel. This includes basic concepts such as
disease recognition and prevention strategies, food hy-
giene and handwashing, respiratory hygiene, cleaning of
common areas, and monitoring for disease symptoms.
In addition, select personnel can be further trained in
the use of personal protective equipment which range
from simple gloves and masks during cleaning of soil-
ages, to full suits against biological attacks.
vAnother area of interest is the use of public health mea-
sures for the prevention and containment of infection, es-
pecially regarding resistant bacteria in the combat wounded
[82]. Environmental studies in military hospitals indicate
the presence of nosocomial transmission of multi-drug re-
sistant pathogens and/or existing colonisation prior to in-
jury [83]. These led to the step-up of education pre-
deployment, standardisation and enhancement of infection
control measures, improved electronic support, and admis-
sion screening for resistant bacteria colonisation [49]. In a
separate study, the conduct of a 5-day infection control
course also showed a 21% improvement in knowledge [84].
Further epidemiological, public health and transla-
tional research provide opportunities for future advance-
ments and better interventions to prevent further spread
and quick containment of infectious diseases.
Vaccination
Since the time George Washington ordered the Contin-
ental army recruits to be vaccinated with smallpoxvaccines in 1777 in response to outbreaks of variola, vac-
cination has evolved to become an integral part of troop
protection against infections [85]. The military has also
contributed to the development of many of these vac-
cines. For instance, the first typhoid vaccine produced
for national supply was by the US Army Medical School
in 1909, based on British and German production
methods. The first inactivated influenza and adenovirus
vaccines [86] were also developed by the US military, be-
coming the first iterations of the vaccines used today.
Furthermore, military sponsored research contributed to
the eventual licensure of ten vaccines from 1945 to 1955
[87]. Table 2 summarises the role to which militaries
have played in the development of vaccines.
Vaccines continue to be under development through
military sponsored studies. For instance, a Phase 3 trial on
an oral adenovirus Type 4 and 7 vaccine was conducted
among US Military recruits [90], with subsequent FDA
approval in 2011. Continued research into vaccines
against dengue, norovirus and HIV continue to be much
anticipated by both military and non-military medical
communities.
Militaries across the world have developed their own
vaccination programs that are often more comprehensive
than their respective civilian populations. The U.S. military
has routine immunisation for infectious diseases influenza
and adenovirus, and travel immunisation depending on
exposure, such as variola vaccination for personnel in
areas at higher risk for release of smallpox as a weapon
[91]. This being so, a World Health Organisation Survey
in the 1990s noted that while 90% of the 52 militaries sur-
veyed claimed to have compulsory military immunisation
schedules, compulsory vaccination for different infectious
diseases varies across militaries from 19% for Measles,
Mumps and Rubella to 87% for tetanus [92].
Chemoprophylaxis and treatment
The use of chemoprophylaxis and treatment against in-
fections in the military continues to be an extensive field
with opportunities for further exploration. During the
American Civil War from 1861 to 1865, three studies on
antiseptics (bromide, turpentine and nitric acid) showed
reductions in mortality from hospital gangrene [93]. Al-
most 80 years later during the Second World War, the
critical discovery of penicillin’s antibiotic effects propelled
it to become second highest priority (behind the atomic
bomb) by the U.S. War Production Board [94]. Its use
has often been cited as pivotal to success of the Allied
Forces [95].
Apart from antibiotics, military medicine has also helmed
developments and innovations in the use of anti-parasitic
and anti-viral chemoprophylaxis. The anti-malarial drug
mefloquine was developed by the Walter Reed Army
Institute in the 1960s, in collaboration with the World
Table 2 Vaccinations and military contributions [85-89]
Vaccine Year initiated Military role
Smallpox 1777 Used by the Continental Army in 1777; Used by Prussian Army
during the Franco-Prussian War in 1870
Yellow fever 1900 Demonstration of etiological agent and vector
Typhoid fever 1909 British Army used early forms during the Anglo-Boer War; US
Military developed killed typhoid vaccine for US Army and
Navy personnel
Tetanus 1940 Used by the US Army and Navy from 1940; Used by the
Luftwaffe in World War II
Cholera 1940, 1980s Injectable whole cell vaccines given to alert US Military Units
until 1973
Hepatitis A 1945, 1985 US Military developed immunoglobulins and used in Korea and
Vietnam in the 1960s; US Military supported safety, immunogenicity
and efficacy studies
Pneumococcus 1945 US Military tested first multivalent polysaccharide vaccine
Diphtheria 1950s US Military sponsored reduced dose formulation
Anthrax 1950s Early anthrax vaccines were developed by Dr George Wright of
the U.S. Chemical Corps and his colleagues, and were licensed
in 1970.
Adenovirus 1952-1969 US Military developed killed bivalent and oral attenuated vaccine
Influenza 1957 US Military developed first iterations of influenza vaccines and
conducted trials among US service members
Japanese Encephalitis 1950s, 1980s US Military performed vaccination efforts in World War II and later
supported inactivated vaccine studies
Plague 1960s US personnel in Vietnam and Southern Vietnam soldiers vaccinated
in the 1960s
Meningococcus 1968 US Military developed polysaccharide vaccine and supported clinical
trials; Adopted by the Israeli Army in 1994
Rubella 1972 US Military developed technique for isolating virus used to develop
the vaccine
Measles 1980 US Military provided funding for development of an attenuated vaccine
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studies also showed synergism between atovaquone and
proguanil, with subsequent co-administration trials con-
ducted at various sites by military-associated laboratories
in Kenya, Brazil and Indonesia. The Influenza A(H1N1)
pdm09 pandemic also saw the effective use of oseltamivir
ring prophylaxis in the Singapore Military in localised
outbreaks to bring about significant reductions in the
reproductive number (the number of new cases attribut-
able to the index case) from 1.91 to 0.11, with significantly
reduced rates of infection [97].
Other drugs have been, or are being evaluated for
possible benefits of chemoprophylaxis in the military
setting. These include the successful use of rifaximin
for the prevention of travellers’ diarrhoea among travellers
and deployed military personnel [98], and dilute Dakin
solution for angioinvasive fungal infection in the com-
bat wounded [99].
Militaries around the world have also implemented
chemoprophylaxis programs against specific threats.
The U.S. military has guidelines for different infectiousdiseases including pre-exposure prophylaxis for malaria
during deployments to affected areas and post-exposure
prophylaxis for anthrax and meningococcus exposure
[91]. The Republic of Korea Army instituted a malaria
prophylaxis program in 1997, and no malaria deaths
have been reported since [100]. In Singapore, malaria
prophylaxis is routinely used for travel to malarious
locations globally. At the same time, on Singapore’s Tekong
Island which houses a military training facility, an inte-
grated combination malaria eradication strategy since
2006 has negated the need for malaria prophylaxis [101].
Co-operation between militaries and Non-military
organisations
Collaborations between different militaries, as well as
between militaries and civilian organisations on various
levels are important in the prevention and control of
infectious disease, and are best performed before the on-
set of outbreaks or epidemics. On a national level, the
interface between the Peruvian military and Royal Thai
Army (described earlier) with their respective national
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information, so as to formulate more appropriate responses
and measures where necessary [78]. On a larger scale,
international networks allow participating countries to
pool resources, providing greater equity. For example, the
AFHSC-GEIS network picked up 76 outbreaks in 53
countries from 2008 to 2009, and involved supporting ci-
vilian entities in 48% of outbreak investigations, including
a number of WHO regional reference laboratories [102].
Civil-military collaborations also play an important
role during humanitarian efforts. After the earthquake in
Haiti in 2010, security established by the military allowed
civilian medical personnel more ready access to patients,
and also provided critical equipment and supplies [103].
The Oslo Guidelines, updated by United Nations in 2007,
provides guidelines for international military aid in dis-
aster relief operations- one key point being that military
assets should only be utilised when there are no viable
alternatives, and with due regard for the sovereignty
and leading role of local authorities [104,105].
Enhancing lab diagnostic capabilities
As early detection plays an important role in the mitiga-
tion of infectious diseases, militaries have a responsibility
to enhance their laboratory capabilities for diagnosis. To
maximise the use of resources, militaries should work
together with civilian laboratories to strengthen national
capabilities in the detection of novel infectious agents
under International Health Regulations, exemplified by
the early detection of Influenza A(H1N1)pdm09 by a U.S.
military laboratory [72]. In addition, militaries sometimes
require rapid diagnosis of common diseases especially
during field deployments where full laboratory facilities
may be unavailable. Enhancing laboratory capacity in mili-
taries should therefore extend to improving capabilities in
field and austere conditions where diseases are often
encountered.
Conclusion
Although the ever-changing infectious diseases scene
and harsh operational and training environment pose
unique and sometimes seemingly daunting challenges to
military organisations, it also presents many opportunities
for scientific advancements in the areas of prevention,
mitigation and control. From surveillance to treatment
and public health measures, the field of infectious diseases
in the military has, more than ever before, many puzzles
waiting to be solved. Military healthcare providers and
administrators involved in this worthwhile endeavour
should also be encouraged that the work they do goes
beyond accruing direct benefits for militaries, often
flowing to the greater community at large. As such,
continued investment in military surveillance, research
and management of infectious diseases is important toensure that the world we live in is safer from the threat
of diseases.
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